Nova NVMI 深 沪
已收盘 11-06 16:00:00 美东时间
313.18
+32.880
+11.73%
华盛通- 最 高316.195
- 今 开305.73
- 成交量 46.36万股
- 最 低 298.60
- 昨 收 280.30
- 总市值 99.61亿
- 52周最高 615.99
- 市盈率 静 39.36
- 换手率 1.46%
- 52周最低 266.4301
- 委 比 -29.20%
- 总股本 3180.62万
- 历史最高 615.99
- 量 比 1.13
- 振 幅 6.28%
- 历史最低 5.11
- 每 手 1
- 风险率 76.76%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多英特尔Nova Lake-S处理器2027年发布，LGA 1954插槽强制主板升级
据最新消息，英特尔下一代桌面处理器Nova Lake-S预计于2027年第一季度正式发布，并将采用全新的LGA 1954处理器插槽。这一变更意味着当前基于LG...
11-08 07:41
欧洲多国航班接连遭遇炸弹威胁 恐慌蔓延至电视台 安全警戒持续升级
①欧洲多国近期接连遭遇炸弹威胁，原本针对民航航班的虚假炸弹警报正进一步蔓延至媒体机构； ②周四欧洲至少有25架次航班受到炸弹威胁影响，部分飞机被迫紧急降落或由战斗机护送抵达目的地； ③此类非常规活动能够以相对简单的方式扰乱社会正常运转，制造恐惧和焦虑。
11-07 03:09
美股大行评级 | 可口可乐、麦当劳、3M等获多家大行看好；机构上调高通目标价至165美元
今日重点评级关注：Citizens：维持Precigen"跑赢大市"评级，目标价从11美元升至12美元；Leerink Partners：维持Arcus Biosciences"跑赢大市"评级，目标价从46美元升至49美元
11-06 16:15
Needham Maintains Buy on Nova, Lowers Price Target to $420
Needham analyst Charles Shi maintains Nova (NASDAQ:NVMI) with a Buy and lowers the price target from $570 to $420.
11-06 01:28
Nova Sees Q4 GAAP EPS $2.78-$2.93 vs $2.78 Est
Nova (NASDAQ:NVMI) is looking for Q4 GAAP EPS of $2.78-$2.93 vs $2.78 analyst estimate..
11-05 20:32
Studsvik Wins First Major Novatron Fusion Reactor Assignment
The latest announcement is out from Studsvik AB ( ($SE:SVIK) ). Studsvik is an ...
11-05 15:59
St Barbara Resumes Ore Processing at Nova Scotia’s Touquoy Mine
An announcement from St. Barbara ( ($AU:SBM) ) is now available. St Barbara Lim...
11-05 05:28
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Milestone Pharmaceuticals Inc. granted 33,000 stock options to a new employee under its 2021 Inducement Plan. The options have a grant date of November 2, 2026, with an exercise price of $0.72 per share, vesting over four years. The Plan is used to incentivize new hires, in compliance with Nasdaq Listing Rule 5635(c)(4). Milestone is a biopharmaceutical company focused on developing cardiovascular medicines, with its lead product CARDAMYST® (etri...
11-04 01:45
XMax Inc. Announces Preliminary Third Quarter 2026 Financial Results
XMax Inc. reported preliminary Q3 2026 financial results with net sales of $6.42M, down from $9.76M in Q3 2025. Gross profit was $0.89M (13.9% margin) vs. 10.1% in Q3 2025. Net loss is expected to range from $12.10M to $13.10M, primarily due to non-cash unrealized losses. For the nine months ended September 30, 2026, net sales were $10.94M vs. $14.95M in 2025, with gross profit at $2.87M (26.2% margin) vs. 23.2% in 2025. Net income is expected to...
11-03 21:30
XMax Announces $30 Million Share Repurchase Program
XMax Inc. announced that its Board of Directors has authorized a share repurchase program allowing the Company to repurchase up to $30 million of its outstanding common stock at prices below $5.50 per share. The program will commence after the Company releases its Q3 2026 financial results and disclose any material nonpublic information, and will expire three months after its start. Repurchases will be made through open-market purchases, potentia...
11-03 13:00
